Christopher Hemond to Epstein-Barr Virus Nuclear Antigens
This is a "connection" page, showing publications Christopher Hemond has written about Epstein-Barr Virus Nuclear Antigens.
Connection Strength
0.227
-
Bose A, Khalighinejad F, Hoaglin DC, Hemond CC. Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review. Mult Scler Relat Disord. 2024 Apr; 84:105410.
Score: 0.227